References
- IPAG Guidelines - (www.theIPCRG.org)
- Allergic rhinitis and its impact on asthma (ARIA) in collaboration with World Health Organisation (WHO) Guidelines. J Allergy Clin Immunol 2001; 108: S147-336
- Bousquet J, Van Cauwenberge P, Khaltaev N, Bond C, Bonini S, Bousquet H, Canonica G, Howarth P, Kowalski ML, Leder JM, Lockey RF, Meltzer EO, Naclerio R, Nekam K, Pia Orru M, Price Simons DFR, Teresi M, Valovirta E, Maurizio Vignola A, Dennis Williams, Wright A. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy. 2004;59:373-87
- Annesie-Maesano, Didier A, Klossek M, Chanal I, Moreau D, Bousquet J. The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies. Allergy 2002; 57: 107-114
- Østergaard MS, Østrem A, Söderström M. Hayfever and a single intramuscular injection of steroides (systemic corticosteroids): A systemic review. As presented at the International Primary Care Research Group (IPCRG) meeting in Melbourne, 2004.
- Thomas M, Price D, Zhang Q, Sazonov Kocevar V. Difference in asthma-related medical resource use among children with asthma with or without concomitant allergic rhinitis in a UK Primary Care Database. Primary Care Respiratory Journal (2004); 13: 105-121
- Price D, Zhang Q, Thomas M, Sazonov Kocevar V. Impact of concomitant allergic rhinitis on asthma-related medical resource use among adults with asthma in the United Kingdom. Primary Care Respiratory Journal (2004); 13: 105 - 121
|
